Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma. A Review

Home / Abstract / Rationale for Immune Checkpoint Inhibitors Plus Targeted Therapy in Metastatic Melanoma. A Review